Package 72162-2483-0

{"route": ["ORAL"], "spl_id": "341a3d04-770f-72c1-e063-6294a90a1287", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "unii": ["0H73WJJ391"], "rxcui": ["199890"], "spl_set_id": ["c320999e-b940-44d8-bf31-2fb78835ac2d"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "1000 TABLET, FILM COATED in 1 BOTTLE (72162-2483-0)", "package_ndc": "72162-2483-0", "marketing_start_date": "20250501"}, {"sample": false, "description": "500 TABLET, FILM COATED in 1 BOTTLE (72162-2483-5)", "package_ndc": "72162-2483-5", "marketing_start_date": "20250501"}, {"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (72162-2483-6)", "package_ndc": "72162-2483-6", "marketing_start_date": "20250501"}], "brand_name": "topiramate", "product_id": "72162-2483_341a3d04-770f-72c1-e063-6294a90a1287", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "72162-2483", "generic_name": "topiramate", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "topiramate", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "200 mg/1"}], "application_number": "ANDA090162", "marketing_category": "ANDA", "marketing_start_date": "20130701", "listing_expiration_date": "20261231"}